Company News 30 Sep 2020 Landmark Publication Points to IC14 Target in ALS-MND ALS-MND is our leading clinical program in neurodegeneration; however Parkinson’s and Alzheimer’s disease are also coming into sharp focus with… Implicit Bioscience
